ATXS vs. CRDF
Compare and contrast key facts about Astria Therapeutics, Inc. (ATXS) and Cardiff Oncology, Inc. (CRDF).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ATXS or CRDF.
Key characteristics
| ATXS | CRDF | |
|---|---|---|
| YTD Return | 24.35% | 137.84% |
| 1Y Return | -24.51% | 80.51% |
| 3Y Return (Ann) | -7.18% | -27.17% |
| 5Y Return (Ann) | -27.19% | -0.56% |
| Sharpe Ratio | -0.36 | 0.78 |
| Daily Std Dev | 69.04% | 113.81% |
| Max Drawdown | -99.72% | -99.96% |
| Current Drawdown | -98.90% | -99.82% |
Fundamentals
| ATXS | CRDF | |
|---|---|---|
| Market Cap | $524.42M | $157.38M |
| EPS | -$2.42 | -$0.93 |
| Revenue (TTM) | $0.00 | $488.00K |
| Gross Profit (TTM) | $0.00 | -$26.72M |
| EBITDA (TTM) | -$32.38M | -$45.01M |
Correlation
The correlation between ATXS and CRDF is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ATXS vs. CRDF - Performance Comparison
In the year-to-date period, ATXS achieves a 24.35% return, which is significantly lower than CRDF's 137.84% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ATXS vs. CRDF - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Astria Therapeutics, Inc. (ATXS) and Cardiff Oncology, Inc. (CRDF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ATXS vs. CRDF - Dividend Comparison
Neither ATXS nor CRDF has paid dividends to shareholders.
Drawdowns
ATXS vs. CRDF - Drawdown Comparison
The maximum ATXS drawdown since its inception was -99.72%, roughly equal to the maximum CRDF drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for ATXS and CRDF. For additional features, visit the drawdowns tool.
Volatility
ATXS vs. CRDF - Volatility Comparison
The current volatility for Astria Therapeutics, Inc. (ATXS) is 13.95%, while Cardiff Oncology, Inc. (CRDF) has a volatility of 31.60%. This indicates that ATXS experiences smaller price fluctuations and is considered to be less risky than CRDF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ATXS vs. CRDF - Financials Comparison
This section allows you to compare key financial metrics between Astria Therapeutics, Inc. and Cardiff Oncology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities